<DOC>
	<DOCNO>NCT02332044</DOCNO>
	<brief_summary>The purpose study evaluate drug-drug interaction Erdosteine Bepotastine besilate healthy adult volunteer .</brief_summary>
	<brief_title>Drug Interaction Study Between Erdosteine Bepotastine Besilate Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Erdosteine</mesh_term>
	<criteria>Healthy male subject age 20 45 year A body mass index range 18.5 25 kg/m2 Willingness participate entire study period Written inform consent fully inform study procedures Any past medical history hepatic , renal , gastrointestinal , respiratory , endocrine , psychiatric , neurologic , haematooncologic cardiovascular disease History clinically significant drug hypersensitivity Use medication within 7 day first dose Heavy drinker/smoker Whole blood donation 60 day study Judged eligible study participation investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>